Potential licensing reforms in light of COVID-19

被引:1
|
作者
Timmons, Edward [1 ]
Norris, Conor [2 ]
机构
[1] West Virginia Univ, John Chambers Coll Business & Econ, Knee Ctr Study Occupat Regulat, Econ, 1601 Univ Ave, Morgantown, WV 26506 USA
[2] West Virginia Univ, John Chambers Coll Business & Econ, Knee Ctr Study Occupat Regulat, 1601 Univ Ave, Morgantown, WV 26506 USA
来源
HEALTH POLICY OPEN | 2022年 / 3卷
关键词
Occupational licensing; Scope of practice; Primary care; BARRIER;
D O I
10.1016/j.hpopen.2021.100062
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In 2020, COVID-19 threatened to overwhelm healthcare capacity, forcing policymakers to enact temporary waivers of licensing restrictions. Research finds that occupational licensing reduces the supply of professionals in a regulated field, and reduces geographic mobility, contributing to the primary care professional shortage. Scope of practice laws reduce the flexibility of practitioners, exacerbating these shortages. Given the fact that policymakers and healthcare professionals recognized the shortcomings to our current licensing regime during the COVID-19 pandemic, we should consider alternatives that still ensure quality care for patients without restricting access and reducing flexibility. We rank six alternatives currently being considered to address the primary care shortage from most to least effective. While efforts to expand the supply of physicians or NPs and PAs would be the most effective reforms to expand access to primary care, others that better utilize our existing supply of healthcare professionals are worth considering.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Simnotrelvir as a potential treatment for COVID-19
    McCarthy, Matthew W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (03) : 233 - 237
  • [42] As a potential treatment of COVID-19: Montelukast
    Fidan, Cihan
    Aydogdu, Ayse
    MEDICAL HYPOTHESES, 2020, 142
  • [43] Potential strategies for combating COVID-19
    Shamim, Saba
    Khan, Maryam
    Kharaba, Zelal Jaber
    Ijaz, Munazza
    Murtaza, Ghulam
    ARCHIVES OF VIROLOGY, 2020, 165 (11) : 2419 - 2438
  • [44] Curcumin as a Potential Treatment for COVID-19
    Rattis, Brune A. C.
    Ramos, Simone G.
    Celes, Mara R. N.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [45] The Rationale for Potential Pharmacotherapy of COVID-19
    Saber-Ayad, Maha
    Saleh, Mohamed A.
    Abu-Gharbieh, Eman
    PHARMACEUTICALS, 2020, 13 (05)
  • [46] Potential Therapeutic Options for COVID-19
    Zheng, Xiaoqin
    Li, Lanjuan
    INFECTIOUS MICROBES & DISEASES, 2020, 2 (03): : 89 - 95
  • [47] Potential Neurologic Manifestations of COVID-19
    Nordvig, Anna S.
    Fong, Kathryn T.
    Willey, Joshua Z.
    Thakur, Kiran T.
    Boehme, Amelia K.
    Vargas, Wendy S.
    Smith, Craig J.
    Elkind, Mitchell S., V
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (02) : E135 - E146
  • [48] Potential role of statins in COVID-19
    Lee, Ken Cheah Hooi
    Sewa, Duu Wen
    Phua, Ghee Chee
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 615 - 617
  • [49] Curcumin as a potential treatment for COVID-19
    Rocha, Francisco Airton Castro
    Assis, Marcos Renato
    PHYTOTHERAPY RESEARCH, 2020, 34 (09) : 2085 - 2087
  • [50] Covid-19 and hypokalaemia - A potential mechanism
    Mandal, Amit K. J.
    Kho, Jason
    Metaxa, Sofia
    Missouris, Constantinos G.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2021, 58 (03) : 259 - 260